Knowledge, attitude and practice of undergraduate medical students and interns towards pharmacovigilance

Tushar R. Bagle; Vijay A. Vare; Rohan C. Hire; Abhaykumar O. Shukla

doi:10.18203/2319-2003.ijbcp20173147

Authors

Tushar R. Bagle Department of Pharmacology, RGMC and CSMH, Kalwa, Thane, Maharashtra, India
Vijay A. Vare Department of Pharmacology, RGMC and CSMH, Kalwa, Thane, Maharashtra, India
Rohan C. Hire Department of Pharmacology, RGMC and CSMH, Kalwa, Thane, Maharashtra, India
Abhaykumar O. Shukla Department of Pharmacology, RGMC and CSMH, Kalwa, Thane, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20173147

Keywords:

ADR, Curriculum, Medical students, Pharmacovigilance, Reporting

Abstract

Background: Medicines had brought revolution in which diseases are treated and controlled. There are several examples in which using nonstandard medicines had led to death of many patients.

Methods: A cross-sectional questionnaire based study in 200 undergraduate medical students, 150 medical students and 50 interns in a tertiary care hospital. There will be 50 each from II MBBS, III MBBS, IV MBBS and Interns.

Results: The mean age was 23.68+1.64 years. In the elements of Pharmacovigilance, 5 students feel it is only detection, 4 for assessment, 1 for understanding, 5 for prevention and 142 (II:22, III:41, IV:36, Intern:43) all of the above elements while 43 don’t know about the elements of Pharmacovigilance. The factors that discourage from reporting ADR, among this did not know how to report was statistically significant compared to other factors. In students view on problems faced while reporting ADR, among them unawareness of the need to report an ADR and lengthy paper work were statistically significant. (69%) feel internet is the best reference aid to gather information on ADR to new medicines while (39.5%) prefer text books.

Conclusions: The learning of PV should start as early as possible in medical school and should be frequently held to increase the Knowledge, attitude and practice of healthcare professionals regarding ADR’s monitoring.

Metrics

Metrics Loading ...

References

World Health Organization. The Safety of Medicines in Public Helath Programmes. Pharmacovigilance an essential tool. World Health Organization. 2006. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf [Accessed 24 March 2017]

World Health Organization. Pharmacovigilance: Ensuring the Safe Use of Medicines - WHO Policy Perspectives on Medicines. Available at: http://apps.who.int/medicinedocs/en/d/Js6164e/1.html [Accessed 23 March 2017]

World Health Organization. Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines. 2004;1-8.

Indian Pharmacopoeia Commission. Pharmacovigilance Programme of India: Frequently Asked Questions in Pharmacovigilance Programme Of India. Available at: http://www.ipc.gov.in/PvPI1/pv_faq.html [Accessed 13 May 2017]

Indian Pharmacopoeia Commission. Pharmacovigilance Programme of India: About PvPI. Available at: http://www.ipc.gov.in/PvPI1/pv_about.html [Accessed 14 May 2017]

Kalaiselvan V. India contribution to WHO-UMC Global Drug safety database for the year 2013. Pharmacovigilance programme of India Newsletter. 2014;8(4):4-5.

Indian Pharmacopoeia Commission. Pharmacovigilance Programme of India: ADR monitoring centres. Available at: http://www.ipc.gov.in/PvPI1/pv_amcs.html [Accessed 14 May2017]

Radhakrishnan R, Vidyasagar S, Varma DM. An Educational Intervention to assess Knowledge Attitude Practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital. International Journal of Pharm Tech Research. 2011;3(2):678-92.

Rehan HS, Sah RK, Chopra D. Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital. Indian J Pharmacol. 2012;44:699-703.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India:An observational study. J Nat Sc Biol Med. 2013;4:191-6.

Reddy LV, Pasha SK, Rathinavelu M, Reddy P. Assessment of Knowledge, Attitude and Perception of Pharmacovigilance and Adverse Drug Reaction Reporting among the Pharmacy Students in South India. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS). 2014:9(2):34-43.

Abubakar AR, Chedi BA, Mohammed KG, Haque M. Perception of Nigerian medical students on adverse drug reaction reporting. J Adv Pharm Technol Res. 2015;6:154‑8.

Kulmi M, Reddy P, Dhakre S, Shinde M, Goyal C. Knowledge, attitude and practices of pharmacovigilance among the postgraduate and undergraduate medical students in a tertiary care hospital in Central India. Int J Basic Clin Pharmacol. 2017;6:1127-32.

Dhananjay K, Esanakula H. A study of assessing knowledge, attitude and practice of pharmacovigilance among medical students of a South Indian teaching hospital. Int J Basic Clin Pharmacol. 2017;6:43-7.

Vakade KP, Sangisetti VM, Binayke MV, Abhavathi VN, Nayak BB. An evaluation of knowledge, attitude and practice of pharmacovigilance among interns in a tertiary care teaching hospital of North Maharashtra. Int J Basic Clin Pharmacol. 2016;5:2321-5.

Meher BR, Joshua N, Asha B, Mukherji D. A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India. Perspect Clin Res. 2015;6:217‑21.

Tabassum R, Bhat MY, Farhat S. A descriptive study of knowledge of Pharmacovigilance and adverse drug reactions among second professional undergraduate medical students in a teaching hospital. Int J Basic Clin Pharmacol. 2015;4:1016-20.

Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB. Knowledge of adverse drug reactions and pharmacovigilance activity among the undergraduate students of Gujarat. Int J Pharm Sci Res. 2012;3:1511-5.

Khan MU, Ahmad A, Ejaz A, Rizvi SA, Sardar A, Hussain K, et al. Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof. 2015;12:28.

Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta Analysis. Plos One. 2016;1(3):e0152221.

Rishi RK, Patel RK, Bhandari A. Under reporting of ADRs by medical practitioners in India- results of pilot study. Adv Pharmacoepidem Drug Saf. 2012;1(3):112-3.

Radhika Rani KC, Hemanth GV, Vasundaradevi B, Sadana A, Prameela G. Assessment of Awareness, Knowledge and Methods Of Application Of Pharmacovigilance Among Internees And Postgraduates In A Government Hospital. International Journal of Medical Science and Clinical Inventions. 2015;2(6):1089-96.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Underreporting of adverse drug reactions:A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47:65-71.

Suveges LG, Gesy KF, Wallace SM, Blackburn JL, Appel WC. Adverse drug reaction reporting part II: evaluation of the Saskatchewan pilot project for a regional reporting program in Canada. Drug Information Journal. 1995;29:581-9.

Bagewadi HG, Rekha MS, Sabari AJ. A comparative evaluation of different teaching aids among fourth term medical students to improve the knowledge, attitude and perceptions about pharmacovigilance: An experimental study. International Journal of Pharmacological Research. 2015;5(4):91-7.

Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47:436-9.

Abubakar AR, Haque M. Pharmacovigilance Practice: The Current Challenges and the Gaps in the Medical Students’ Curriculum. J App Pharm Sci. 2016;6(05):210-5.

Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48:S69-73.